IQVIA Whitepaper on the Natural History of Disease Features Discussions on RWE, Big Data, and COVID-19

A recent IQVIA whitepaper brought together multidisciplinary experts to discuss the natural history of disease. The discussion focused on the role of real world evidence (RWE), managing large datasets, dealing with the effects of COVID-19, and assessing a drug’s value amid unclear data.

“In the course of the two-hour conversation, participants discussed the uncertainties pertaining to the molecular pathways of disease, the challenges relating to the use of big data seen through the lens of cancer and neurodegenerative diseases, the role of pre-symptomatic disease, the impact of social determinants of health, and the application of real world evidence to support the evolving understanding of the natural history of disease.” Learn more here.

(Source: IQVIA Institute for Human Data Science, 8/28/20)